Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22274331 | 0.99 | MEN1 (0.36) | MEN1KMT2AATMCYP1A2ERBB2 | |
| SCHEMBL22273885 | 0.95 | MEN1 (0.36) | MEN1KMT2AATMCYP1A2ERBB2 | |
| SCHEMBL22274335 | 0.94 | CYP1A2 (0.34) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL22274336 | 0.93 | CYP1A2 (0.35) | MEN1KMT2AATMCYP1A2ERBB2 | |
| SCHEMBL22274339 | 0.93 | CYP1A2 (0.32) | MEN1KMT2AATMCYP1A2ERBB2 | |
| SCHEMBL24280731 | 0.92 | CYP1A2 (0.34) | MEN1KMT2ACYP1A2ERBB2FYN | |
| SCHEMBL22274338 | 0.92 | CYP1A2 (0.34) | MEN1KMT2AATMCYP1A2ERBB2 | |
| SCHEMBL22273886 | 0.92 | CYP1A2 (0.34) | MEN1KMT2AATMCYP1A2ERBB2 | |
| SCHEMBL22273888 | 0.89 | ERBB2 (0.33) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL22274099 | 0.89 | MAPT (0.34) | MEN1KMT2AATMCYP1A2ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-17 | — | — | US | disclosed |
| WO-2020153758-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | ALDH1A2, OXER1, AOX1 | MEN1 3195/4885KMT2A 3054/4885ATM 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.